Smith AA - Search Results

1

Polymers fight HIV: potent (pro)drugs identified through parallel automated synthesis.

Zuwala K, Smith AA, Postma A, Guerrero-Sanchez C, Ruiz-Sanchis P, Melchjorsen J, Tolstrup M, Zelikin AN. Zuwala K, et al. Among authors: smith aa. Adv Healthc Mater. 2015 Jan 7;4(1):46-50. doi: 10.1002/adhm.201400148. Epub 2014 May 9. Adv Healthc Mater. 2015. PMID: 24811313

2

Macromolecular prodrugs of ribavirin: concerted efforts of the carrier and the drug.

Smith AA, Wohl BM, Kryger MB, Hedemann N, Guerrero-Sanchez C, Postma A, Zelikin AN. Smith AA, et al. Adv Healthc Mater. 2014 Sep;3(9):1404-7. doi: 10.1002/adhm.201300637. Epub 2014 Jan 10. Adv Healthc Mater. 2014. PMID: 24408515

3

Highly active macromolecular prodrugs inhibit expression of the hepatitis C virus genome in the host cells.

Ruiz-Sanchis P, Wohl BM, Smith AA, Zuwala K, Melchjorsen J, Tolstrup M, Zelikin AN. Ruiz-Sanchis P, et al. Among authors: smith aa. Adv Healthc Mater. 2015 Jan 7;4(1):65-8. doi: 10.1002/adhm.201400307. Epub 2014 Aug 7. Adv Healthc Mater. 2015. PMID: 25132665

4

Disulfide reshuffling triggers the release of a thiol-free anti-HIV agent to make up fast-acting, potent macromolecular prodrugs.

Kock A, Zuwala K, Smith AA, Ruiz-Sanchis P, Wohl BM, Tolstrup M, Zelikin AN. Kock A, et al. Among authors: smith aa. Chem Commun (Camb). 2014 Dec 4;50(93):14498-500. doi: 10.1039/c4cc04280h. Chem Commun (Camb). 2014. PMID: 25285337

5

Macromolecular (pro)drugs with concurrent direct activity against the hepatitis C virus and inflammation.

Wohl BM, Smith AA, Jensen BE, Zelikin AN. Wohl BM, et al. Among authors: smith aa. J Control Release. 2014 Dec 28;196:197-207. doi: 10.1016/j.jconrel.2014.09.032. Epub 2014 Oct 16. J Control Release. 2014. PMID: 25451544

6

Self-Immolative Linkers Literally Bridge Disulfide Chemistry and the Realm of Thiol-Free Drugs.

Riber CF, Smith AA, Zelikin AN. Riber CF, et al. Among authors: smith aa. Adv Healthc Mater. 2015 Aug 26;4(12):1887-90. doi: 10.1002/adhm.201500344. Epub 2015 Jun 24. Adv Healthc Mater. 2015. PMID: 26109168

7

Triple Activity of Lamivudine Releasing Sulfonated Polymers against HIV-1.

Danial M, Andersen AH, Zuwala K, Cosson S, Riber CF, Smith AA, Tolstrup M, Moad G, Zelikin AN, Postma A. Danial M, et al. Among authors: smith aa. Mol Pharm. 2016 Jul 5;13(7):2397-410. doi: 10.1021/acs.molpharmaceut.6b00156. Epub 2016 Jun 15. Mol Pharm. 2016. PMID: 27244595

8

Macromolecular prodrugs of ribavirin combat side effects and toxicity with no loss of activity of the drug.

Kryger MB, Wohl BM, Smith AA, Zelikin AN. Kryger MB, et al. Among authors: smith aa. Chem Commun (Camb). 2013 Apr 4;49(26):2643-5. doi: 10.1039/c3cc00315a. Chem Commun (Camb). 2013. PMID: 23431562

9

Macromolecular prodrugs for controlled delivery of ribavirin.

Kryger MB, Smith AA, Wohl BM, Zelikin AN. Kryger MB, et al. Among authors: smith aa. Macromol Biosci. 2014 Feb;14(2):173-85. doi: 10.1002/mabi.201300244. Epub 2013 Sep 17. Macromol Biosci. 2014. PMID: 24105953

10

Cholesterol modification of (Bio)polymers using UV-Vis traceable chemistry in aqueous solutions.

Rasmussen KF, Smith AA, Ruiz-Sanchis P, Edlund K, Zelikin AN. Rasmussen KF, et al. Among authors: smith aa. Macromol Biosci. 2014 Jan;14(1):33-44. doi: 10.1002/mabi.201300286. Epub 2013 Sep 17. Macromol Biosci. 2014. PMID: 24106046

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

566 results

Search Page

Filters